You are here: All Products  > FibroGen/AstraZeneca Novel Anemia Drug Approved in China -- Before US/EU Approvals

FibroGen/AstraZeneca Novel Anemia Drug Approved in China -- Before US/EU Approvals

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products